The Hematology division provides advanced care for patients with rare blood disorders, as well as an important supportive role for all other tertiary-care programs at the MUHC.
- Acquired Disorders of Haemostasis and Coagulation
- Avascular Necrosis
- Congenital Disorders of Haemostasis and Coagulation
- Extracorporeal Photopheresis
- Hematological Disorders in High Risk Pregnancy
- Hematology Laboratory Medicine
- Hereditary Disorders of Red Cells / Hemoglobinopathies
- Immune Cytopenias
- Iron Metabolism
- Plasma Pheresis
- Stem Cell Transplantation
The Congenital Disorders of Coagulation Clinic (Hemophilia Clinic) and the hemoglobinopathies clinics provide expert comprehensive care. The clinics also incorporate essential elements of research, transitional care and collaboration with other programs in Québec and Canada. This is one of four designated hemophilia centres in the province and has the responsibility of managing coagulation products.
Sickle Cell Clinic
The Sickle Cell Clinic, like many others in Canada, is a developing program, and with the improving organizational structure of the CanHaem Group, will lead to superior care and research initiatives for this vulnerable and growing set of patients.
Hematological Disorders in Pregnancy Clinic
The Hematological Disorders in Pregnancy Clinic offers expert care for patients in the high-risk pregnancy program, and is an essential component of the Women’s Health Mission. All of these activities are considered tertiary-level care and the MUHC has one of the few available centres in Quebec.
The MUHC Plasmapheresis Unit is the most active in Canada and is essential in supporting the needs of the Montreal Neurological Institute and Hospital. It is also developing and implementing a provincially-designated joint photopheresis program, along with Maisonneuve-Rosemont Hospital, for the management of stem cell transplant and T-cell leukemia/lymphoma patients.
The MUHC Transfusion Service is a provincially-designated transfusion centere and the largest within the province, with 25,000 red blood cell units transfused annually. The activities of our Transfusion Centre are recognized within the province of Québec, for innovations related to blood product needs in the far North of the province.
The Immunodeficiency research team, led by Dr. Jean-Pierre Routy, has produced valuable collaborative efforts in HIV vaccine development, dendritic cell therapy and the establishment of a unique cell bank for research. This work has led to important research grants from multiple funding agencies, including the CIHR, FRSQ and NIH, and numerous publications in highly respected journals, such as Nature Medicine. Dr. Routy has spoken at international HIV conferences and has been recognized as the “personality of the week” by La Presse. The clinic is an integrated unit located at the Montreal Chest Institute, which allows patients with AIDS-related tumours to be treated and to have their antiretroviral medication monitored by the Immunodeficiency team.